We observed activation of NF-κB signaling and activation of target genes, TNF-α, IL-6, and CCL5, following exposure of hepatocytes to exosomes isolated from plasma of COVID-19 patients (Figure 6). The gene discussed is NFKB1; the disease is COVID-19.